ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1111

Huntingtin Interactin Protein 1 (HIP1) Regulates Receptor Tyrosine Kinases Mediated Activity and Cell Invasiness in Fibroblast-like Synoviocytes

Teresina Laragione, Nasim Azizgolshani, Carolyn Harris, Erjing Gao and Percio Gulko, Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Animal models, joint damage, pathogenesis, rheumatoid arthritis, synovial fluid, synovium and synovial cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Biology and Pathology of Bone and Joint - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Huntingtin-interacting protein 1 (Hip1) is a new arthritis severity gene recently identified in the Pristane and Collagen-induced arthritis (PIA, CIA) quantitative trait locus Cia25/Pia42 on rat chromosome 12. This study aimed to characterize the mechanism of action of Hip1 in arthritis.

Methods: Synovial tissues and fibroblast-like synoviocytes (FLS) were obtained from DA and DA.ACI(Cia25/Pia42) subcongenic R6 (R6) rats (day 21 after the onset of PIA). FLS from DA and the DA.ACI(Cia25/Pia42) subcongenic R6 (R6) were treated with PDGF, EGF, 10% FBS or 0.1% FBS and studied for a) in vitro invasion in a two-chamber assay through Matrigel, b) proliferation, c) gene expression (qPCR) analysis. DA and rheumatoid arthritis (RA) FLS were also studied following siRNA knockdown of Hip1. Tissues from Hip1 knockout mice were used for qPCR.

Results:  Synovial tissues from DA rats expressed higher levels of Hip1 compared with DA.ACI(Cia25/Pia42) (1.78-fold). FLS from DA were five-fold more invasive than FLS from protected DA.ACI(Cia25/Pia42)-R6 subcongenics. Hip1 siRNA knockdown reduced the invasiveness of DA FLS and RA FLS by 60% and 50%, respectively demonstrating a critical role for Hip1 in cell invasion. Hip1 is known to interact with receptor tyrosine kinases (RTKs). Therefore, we examined 84 PDGF pathway genes in FLS and detected 16 up and 12 down in DA, compared with R6 subcongenics, including PDGFR, IGFR and EGFR. siRNA knock down of Hip1 in DA FLS reduced the levels of these RTKs to nearly zero, with similar reductions in expression levels detected in tissues from Hip1 knock-out mice. We examined cell invasion in response to PDGFb and detected a more pronounced increase on mean DA FLS invasiveness (12-fold) compared with R6 FLS (7-fold). In the presence of low serum conditions (0.1% FBS) DA FLS also had increased growth rate compared with R6 subcongenic FLS, a characteristic previously reported in Hip1 transfected cells.

Conclusion:  We describe new evidence suggesting increased expression and activity of Hip1 in arthritis-derived FLS. Our results suggest that Hip1 regulates different aspect of FLS behavior favoring survival and proliferation, as well as invasivess in FLS from arthritic rats and from patients with RA. Hip1 also regulates the expression levels and activity of RTKs and their response to ligands such as PDGFb. These new discoveries provide new understanding about event regulating FLS behavior in arthritis and have the potential to generate a new prognostic biomarkers and a new intra-cellular target for therapy.


Disclosure: T. Laragione, None; N. Azizgolshani, None; C. Harris, None; E. Gao, None; P. Gulko, None.

To cite this abstract in AMA style:

Laragione T, Azizgolshani N, Harris C, Gao E, Gulko P. Huntingtin Interactin Protein 1 (HIP1) Regulates Receptor Tyrosine Kinases Mediated Activity and Cell Invasiness in Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/huntingtin-interactin-protein-1-hip1-regulates-receptor-tyrosine-kinases-mediated-activity-and-cell-invasiness-in-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/huntingtin-interactin-protein-1-hip1-regulates-receptor-tyrosine-kinases-mediated-activity-and-cell-invasiness-in-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology